The NANOS Annual Meeting Neuro-Ophthalmology Collection: Presentations from the annual meeting of the North American Neuro-Ophthalmology Society (NANOS), a professional organization of more than 600 members who are fully trained ophthalmologists or neurologists. Contains records from the first meeting in 1975 to the present.
NOVEL: https://novel.utah.edu/
TO
1 - 25 of 10
| Title | Creator | Relation Is Part Of | ||
|---|---|---|---|---|
| 1 |
 |
Frequency of Carotid Intraplaque Hemorrhage on Vessel Wall Imaging in Patients with Retinal Artery Occlusion | Anthony Larson, John Chen, M. Tariq Bhatti, James Klaas, Giuseppe Lanzino, John Huston, Waleed Brinjikji | NANOS Annual Meeting 2021: Scientific Platform I |
| 2 |
 |
Visual Impairment in Patients with Giant Cell Arteritis Treated with Tocilizumab in Real-World Clinical Practice | Timothy McCulley, Jinglan Pei, Paris Sidiropoulos, Christine Birchwood, Jennie Best, John Stone, Sebastian Unizony | NANOS 2019: Scientific Platform III |
| 3 |
 |
Glucagon-Like Peptide-1 and Lipid Metabolism Are Associated With a Reduction in Intracranial Pressure in Idiopathic Intracranial Hypertension | Zerin Alimajstorovic; James L. Mitchell; Andreas Yiangou; Thomas Hancox; Andrew Southam; Olivia Grech; Ryan Ottridge; Catherine Winder; Abd Tahrani; Tricia Tan; Susan Mollan; Warwick Dunn; Alexandra Sinclair | NANOS Annual Meeting 2023: Scientific Platform Session II: https://novel.utah.edu/collection/NAM/toc/ |
| 4 |
 |
The Useful Dynamic Ranges for Visual Field Progression with Stimulus Sizes III and V (video) | Michael Wall, K. Zamba, Paul Artes | NANOS Annual Meeting 2017: Applications of Advanced Retinal Vascular Imaging in Neuro-Ophthalmology |
| 5 |
 |
Neuro-Ophthalmic Consequences of Medications for Multiple Sclerosis: The Good, The Bad, The Ugly and The Unknown (video) | Heather E. Moss, MD, PhD | NANOS Annual Meeting 2017: Neuro-Ophthalmologic Side Effects of More Recently Used Medications in Treating Cancer, Rheumatologic Disorders, and Multiple Sclerosis |
| 6 |
 |
Characterization of Subclinical Optic Nerve MRI Lesions in the N-Momentum Trial | Jeffrey Bennett; Friedemann Paul; John Chen; Michael Smith; Daniel Cimbora; Kristina Patterson; Bruce Cree | NANOS Annual Meeting 2023: Scientific Platform Session III: https://novel.utah.edu/collection/NAM/toc/ |
| 7 |
 |
Efficacy of Chronic Immunotherapy for Myelin Oligodendrocyte Glycoprotein-IgG Disease | John Chen, Collin McClelland, Eric Eggenberger, Alfonso Lopez Chiriboga, Victoria Pelak, Heather Moss, Aubrey Gilbert, Michael Lee, Marie Acierno, Muhammad Bhatti, Jiraporn Jitprapaikulsan, Gregory Van Stavern, Divyanshu Dubey, Andrew McKeon, Jeffrey Bennett, Sean Pittock, Eoin Flanagan, Ore-ofe Ade... | NANOS 2019: Scientific Platform III |
| 8 |
 |
Pathogenic NR2F1 Variants Cause a Systemic Neurodevelopmental Ocular Phenotype Recapitulated in a Mutant Mouse Model | Neringa Jurkute, Michele Bertacchi, Gavin Arno, Chiara Tocco, Ungsoo Kim, Adam Kruszewski, Robert Avery, Emma Bedoukian, Jinu Han, Sung Ahn, James Acheson, Indran Davagnanam, Richard Bowman, Marios Kaliakatsos, Ashwin Reddy, Ngozi Oluonye, Patrizia Amati-Bonneau, Majida Charif, Guy Lenaers, Isabelle... | NANOS Annual Meeting 2021: Scientific Platform I |
| 9 |
 |
Safety and Tolerability of Acetazolamide (Video) | Martin ten Hove, MD, M.Eng, FRCS(C), Queen's University, Kingston, ON | NANOS Annual Meeting 2015 Sizzling Hot Topic: The IIHTT: What Have We Learned? |
| 10 |
 |
Acute Therapeutic Options for CRAO: To TPA or Not? | Oana M. Dumitrascu, MD, MS | NANOS Annual Meeting 2023: Hot Topics: https://novel.utah.edu/collection/NAM/toc/ |
1 - 25 of 10